Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

nhibitors; and the enabling capabilities of Cytokinetics biological focus. Such statements are based on management s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, that GSK or the NCI may decide to postpone or discontinue development efforts for GSK-923295 or ispinesib, respectively; that there may be difficulties or delays potential difficulties or delays in the development, testing, regulatory approval, production and marketing of Cytokinetics drug candidates that could slow or prevent clinical development, product approval or market acceptance, including risks that current and past results of clinical trials or preclinical studies may not be indicative of future clinical trials results, patient enrollment for clinical trials may be difficult or delayed, Cytokinetics drug candidates may have unexpected adverse side effects or inadequate therapeutic efficacy, and Cytokinetics may not be able to obtain and maintain patent or trade secret protection for its intellectual property; that Cytokinetics may incur unanticipated research and development and other costs or be unable to obtain additional financing if necessary; and that standards of care may change or others may introduce products or alternative therapies for the treatment of indications which Cytokinetics drug candidates and potential drug candidates currently or potentially target. For further information regarding these and other risks related to Cytokinetics business, investors should consult Cytokinetics filings with the Securities and Exchange Commission.


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/4/2015)... 4, 2015 Following the reintroduction of ... Center (LAC) released a report today urging policymakers ... and heroin epidemic through more effective use of ... "The Case for Expanding Access to Medication-Assisted Treatment ... the health, justice, and economic advantages of medication-assisted ...
(Date:3/4/2015)...  Bayer HealthCare today announced that the U.S. ... company,s Biologics License Application (BLA) for BAY 81-8973, ... FDA approval of the investigational compound, proposed trade ... in children and adults. "Bayer ... hemophilia A patients who need them," said ...
(Date:3/4/2015)... --  HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... is scheduled to present at the 2015 Barclays ... Tuesday, March 10, 2015.  The conference is being held ... Florida . A live ...
Breaking Medicine Technology:Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2
... 2012 Ziehm Imaging, leading developer, ... award-winning product portfolio at this year,s Charing Cross ... ), its UK distribution partner, Ziehm Imaging showcases ... cardiologists to provide them with a flexible, cost-efficient ...
...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the first quarter ... before the opening of the financial markets. ... also host a conference call at 9:00 a.m. Eastern ...
Cached Medicine Technology:CX 2012: Elevating the Boundaries of Interventional Imaging with Mobile C-arms 2NxStage® to Report First Quarter Fiscal 2012 Financial Results 2
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
(Date:3/4/2015)... 2015 Vancouver chiropractic clinic, Backs ... awards in the prestigious Vancouver Courier “Stars of ... 2015. The company secured third place in the ... “Best Registered Massage Therapist” category. , As ... Canada, The Vancouver Courier is a semiweekly local ...
(Date:3/4/2015)... As seen on Advanced Fertility Center ... a painful condition in which the lining of the ... leading to very unpleasant symptoms and complications that greatly ... terrible effect on women’s quality of life due to ... cause of infertility in women and carries a huge ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The ... downstream client survey, marketing channels, industry development trend ... of the industry, including spices definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
(Date:3/4/2015)... 04, 2015 Plungerhead has ... service members during and after their service to the ... increase awareness through advertising, social media and several national ... patriotic organization through a special retail promotion of Plungerhead ... March through May 2015. , “There is a ...
Breaking Medicine News(10 mins):Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3
... a new surge of scientific research has uncovered telltale ... scans and spinal taps, many questions remain unanswered about ... direction of patient care, according to Dr. Kenneth S. ... of California and co-director of UCSB,s Neuroscience Research Institute. ...
... By Amanda Gardner HealthDay Reporter , ... reacting with dismay to Monday,s decision by a U.S. ... research using federal funds. The temporary injunction, which ... cell research back to the pre-2001 days. That was ...
... (Aug. 24, 2010) What does it feel like to ... now, it has been difficult during astronaut training to realistically ... Dr. Steven Moore leads a research group that ... induces the sensory and mobility disturbances commonly experienced by astronauts ...
... A University of Illinois food science professor has two important ... that have motivated her work in helping to develop a ... a lot of the omega-3 fatty acids found in fish ... from breast milk or formula to solid food, most of ...
... that plays an important role in social behaviorit has ... Increased levels of OT have been associated with greater ... trust in just anybody or does it act more ... catholique de Louvain (Belgium) and her colleagues investigated just ...
... Commission has certified UT Southwestern University Hospital St. ... hospitals fostering specialized stroke care for patients. Expertly ... technicians have ready access to the technology and medications ... Each year about 700,000 people experience a new or ...
Cached Medicine News:Health News:Are early testing and drug development the most pressing issues in Alzheimer's care? 2Health News:Scientists Dismayed by Stem Cell Research Ruling 2Health News:Scientists Dismayed by Stem Cell Research Ruling 3Health News:System uses electrical trickery on the brain to induce realistic spaceflight effects 2Health News:System uses electrical trickery on the brain to induce realistic spaceflight effects 3Health News:Salmon baby food? Babies need omega-3s and a taste for fish, scientist says 2Health News:Study suggests oxytocin makes people trusting, but not gullible 2Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 2Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 3
... Utilizing process automation, robust interfaces ... EMR/Practice Management), and rules-based technology, ... improves efficiency, reduces errors, and ... Harvest LIS includes many powerful, ...
... The Bio-Optics LSM-12000 is a new ... powerful new tool in anterior segment diagnostics ... easy to operate, easy to maintain, and ... is the only High Magnification Slit-Lamp Biomicroscope ...
... 28 Hue test studies the characteristic ... Farnsworth D15, however this 28 hue ... of sensitivity. Case comes with a ... readable. Kit includes laminated scoring template ...
This is a reduced form of the 100 Hue test and L'Anthony New Color Test. The 40 Hue test is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score...
Medicine Products: